RETRACTED ARTICLE: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

被引:0
|
作者
Xiao Fu
Mengjie Liu
Shengyang Qu
Jiequn Ma
Yamin Zhang
Tingting Shi
Hongqing Wen
Yujuan Yang
Shuhong Wang
Jing Wang
Kejun Nan
Yu Yao
Tao Tian
机构
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Medical Oncology
[2] Third Hospital of Xi’an,Department of Respiratory
[3] Shaanxi Provincial People’s Hospital,The Third Department of Cardiology
关键词
microRNA-32-5p; PTEN; Exosome; Hepatocellular carcinoma; Multidrug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] RETRACTED: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway (Retracted Article)
    Fu, Xiao
    Liu, Mengjie
    Qu, Shengyang
    Ma, Jiequn
    Zhang, Yamin
    Shi, Tingting
    Wen, Hongqing
    Yang, Yujuan
    Wang, Shuhong
    Wang, Jing
    Nan, Kejun
    Yao, Yu
    Tian, Tao
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [2] Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/AKT pathway
    Fu, X.
    Liu, M.
    Qu, S.
    Ma, J.
    Zhang, Y.
    Shi, T.
    Wen, H.
    Yang, Y.
    Wang, S.
    Wang, J.
    Nan, K.
    Yao, Y.
    Tian, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 6 - 6
  • [3] Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
    Xiao Fu
    Mengjie Liu
    Shengyang Qu
    Jiequn Ma
    Yamin Zhang
    Tingting Shi
    Hongqing Wen
    Yujuan Yang
    Shuhong Wang
    Jing Wang
    Kejun Nan
    Yu Yao
    Tao Tian
    Journal of Experimental & Clinical Cancer Research, 42
  • [4] RETRACTION: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway (Retraction of Vol 37, art no 52, 2018)
    Fu, Xiao
    Liu, Mengjie
    Qu, Shengyang
    Ma, Jiequn
    Zhang, Yamin
    Shi, Tingting
    Wen, Hongqing
    Yang, Yujuan
    Wang, Shuhong
    Wang, Jing
    Nan, Kejun
    Yao, Yu
    Tian, Tao
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [5] Anti-miR-32-5p therapy reverses multidrug resistance in hepatocellular carcinoma through inhibiting the PI3K/Akt pathway.
    Fu, Xiao
    Liu, Mengjie
    Wen, Hongqing
    Wang, Shuhong
    Yang, Yujuan
    Nan, Kejun
    Yao, Yu
    Tian, Tao
    HEPATOLOGY, 2017, 66 : 372A - 372A
  • [6] FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
    L Cheng
    S Luo
    C Jin
    H Ma
    H Zhou
    L Jia
    Cell Death & Disease, 2013, 4 : e923 - e923
  • [7] FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
    Cheng, L.
    Luo, S.
    Jin, C.
    Ma, H.
    Zhou, H.
    Jia, L.
    CELL DEATH & DISEASE, 2013, 4 : e923 - e923
  • [8] microRNA-32-5p targets KLF2 to promote gastric cancer by activating PI3K/AKT signaling pathway
    Wang, Qingqing
    He, Yuan
    Kan, Weidiong
    Li, Fucai
    Ji, Xiangjun
    Wu, Xuewen
    Wang, Xinyue
    Zhang, Yue
    Chen, Jinlian
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (08): : 4895 - 4908
  • [9] RETRACTED: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway (Retracted Article)
    Wen, Shu
    Hu, Meng
    Xiong, Yan
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [10] RETRACTED: Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway (Retracted Article)
    Yang, Chendong
    Hou, Aihua
    Yu, Chunfeng
    Dai, Lingling
    Wang, Wen
    Zhang, Kangle
    Shao, Hongmin
    Ma, Jinghua
    Xu, Wenjuan
    ONCOTARGETS AND THERAPY, 2018, 11 : 983 - 996